Foundry Partners, LLC Gsk PLC Transaction History

Foundry Partners, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 23, 2020	SELL	$38.11 - $42.99 $9.9 Million - $11.2 Million	-259,745 Closed	0 $0
Q2 2020 Aug 03, 2020	SELL	$37.87 - $43.58 $814,924 - $937,798	-21,519 Reduced 7.65%	259,745 $10.6 Million
Q1 2020 May 08, 2020	BUY	$32.47 - $48.83 $34,093 - $51,271	1,050 Added 0.37%	281,264 $10.7 Million
Q4 2019 Feb 10, 2020	BUY	$42.0 - $48.25 $11.8 Million - $13.5 Million	280,214 New	280,214 $13.2 Million
Q3 2019 Oct 23, 2019	SELL	$40.46 - $43.52 $13.6 Million - $14.6 Million	-335,495 Closed	0 $0

Q2 2019 Jul 18, 2019	BUY	$39.4 - $42.7 $6.7 Million - $7.26 Million	169,985 Added 102.7%	335,495 $13.4 Million
Q1 2019 Apr 22, 2019	BUY	$38.57 - $42.69 $6.38 Million - $7.07 Million	165,510 New	165,510 $6.92 Million
Q2 2018 Jul 19, 2018	SELL	$39.61 - $42.76 $7.45 Million - $8.04 Million	-188,010 Closed	0 $0
Q1 2018 May 16, 2018	SELL	$36.18 - $40.15 $14,472 - $16,060	-400 Reduced 0.21%	188,010 $7.35 Million
Q4 2017 Jan 25, 2018	SELL	$35.34 - $41.9 $335,553 - $397,840	-9,495 Reduced 4.8%	188,410 $6.68 Million
Q3 2017 Oct 31, 2017	BUY	$39.44 - $41.55 $7.81 Million - $8.22 Million	197,905	197,905 $8.04 Million

175K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $77.7B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Foundry Partners, LLC with notifications on news.